Global Rosuvastatin Calcium

Rosuvastatin Calcium Comprehensive Study by Type (Purity 98.0%, Purity 99.0%, Other), Application (Capsule, Gel, Tablet), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Form (Tablet, Capsule, Others) Players and Region - Global Market Outlook to 2027

Rosuvastatin Calcium Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Rosuvastatin Calcium
Rosuvastatin calcium is the active pharmaceutical ingredient for the once-a-day dyslipidemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke. Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The market is fragmented with numerous players focusing on technique and quality of the product due to which the global rosuvastatin calcium market can witness an upsurge in the forecast period. Analyst at AMA Research estimates that Chinese Players will contribute the maximum growth to Global Rosuvastatin Calcium market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Nanjing Frochem Tech (China), Zhejiang Jingxin Pharmaceutical Co. Ltd. (China), Cadila Pharmaceuticals (India), MSN Laboratories Pvt.Ltd. (India), Lianyungang Runzhong Pharmaceutical (China), LGM Pharma (United States), CTX Life Sciences Pvt. Ltd. (India), HEC Pharma Co., Ltd (China), Teva Pharmaceutical Industries Ltd. (Israel), Bal Pharma Ltd. (India) and Changzhou Pharmaceutical Factory (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Lunan Pharmaceutical (China) and Zhejiang Hisun Pharmaceutical Co., Ltd. (China).

Segmentation Overview
AMA Research has segmented the market of Global Rosuvastatin Calcium market by Type (Purity 98.0%, Purity 99.0% and Other), Application (Capsule, Gel and Tablet) and Region.



On the basis of geography, the market of Rosuvastatin Calcium has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Rosuvastatin Calcium market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Form, the sub-segment i.e. Tablet will boost the Rosuvastatin Calcium market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Rosuvastatin Calcium Market Dynamics:
AttributesDetails
Growth Drivers
  • Change of lifestyle and Growing Aging of the Population
  • Increasing Incidence of Cardiovascular Diseases (CVD) and Obesity
Influencing Trends
  • Increased Demand from Developing Regions
Restraints
  • Issue related to Side Effect of Drugs such as Headache,
  • Muscle Pain, etc.
Road Blocks / Challenges
  • Safety & Quality Concerns as well as Changing Trade Policies between Countries
Gaps & Opportunities
  • High Growth Opportunities in Countries with a High Prevalence Cardiovascular Disease
  • Growing Demand from Emerging Market such as China, India, Brazil, among others


Market Leaders and their expansionary development strategies
In Mar 2019, Orphanion AG and LGM Pharma, LLC announced that they have finalized a partnering agreement. Under the terms of the agreement, Orphanion’s specialty services, such as the production of difficult-to-synthesize molecules for niche applications, will be available to LGM Pharma clients.



Key Target Audience
Manufacturers of Rosuvastatin Calcium, Suppliers of Rosuvastatin Calcium, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Purity 98.0%
  • Purity 99.0%
  • Other
By Application
  • Capsule
  • Gel
  • Tablet
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Form
  • Tablet
  • Capsule
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Change of lifestyle and Growing Aging of the Population
      • 3.2.2. Increasing Incidence of Cardiovascular Diseases (CVD) and Obesity
    • 3.3. Market Challenges
      • 3.3.1. Safety & Quality Concerns as well as Changing Trade Policies between Countries
    • 3.4. Market Trends
      • 3.4.1. Increased Demand from Developing Regions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rosuvastatin Calcium, by Type, Application, Distribution Channel, Form and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Rosuvastatin Calcium (Value)
      • 5.2.1. Global Rosuvastatin Calcium by: Type (Value)
        • 5.2.1.1. Purity 98.0%
        • 5.2.1.2. Purity 99.0%
        • 5.2.1.3. Other
      • 5.2.2. Global Rosuvastatin Calcium by: Application (Value)
        • 5.2.2.1. Capsule
        • 5.2.2.2. Gel
        • 5.2.2.3. Tablet
      • 5.2.3. Global Rosuvastatin Calcium by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
      • 5.2.4. Global Rosuvastatin Calcium by: Form (Value)
        • 5.2.4.1. Tablet
        • 5.2.4.2. Capsule
        • 5.2.4.3. Others
      • 5.2.5. Global Rosuvastatin Calcium Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Rosuvastatin Calcium (Volume)
      • 5.3.1. Global Rosuvastatin Calcium by: Type (Volume)
        • 5.3.1.1. Purity 98.0%
        • 5.3.1.2. Purity 99.0%
        • 5.3.1.3. Other
      • 5.3.2. Global Rosuvastatin Calcium by: Application (Volume)
        • 5.3.2.1. Capsule
        • 5.3.2.2. Gel
        • 5.3.2.3. Tablet
      • 5.3.3. Global Rosuvastatin Calcium by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital Pharmacies
        • 5.3.3.2. Retail Pharmacies
        • 5.3.3.3. Online Pharmacies
      • 5.3.4. Global Rosuvastatin Calcium by: Form (Volume)
        • 5.3.4.1. Tablet
        • 5.3.4.2. Capsule
        • 5.3.4.3. Others
      • 5.3.5. Global Rosuvastatin Calcium Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Rosuvastatin Calcium (Price)
      • 5.4.1. Global Rosuvastatin Calcium by: Type (Price)
  • 6. Rosuvastatin Calcium: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Nanjing Frochem Tech (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Zhejiang Jingxin Pharmaceutical Co. Ltd. (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cadila Pharmaceuticals (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MSN Laboratories Pvt.Ltd. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Lianyungang Runzhong Pharmaceutical (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. LGM Pharma (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CTX Life Sciences Pvt. Ltd. (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. HEC Pharma Co., Ltd (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bal Pharma Ltd. (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Changzhou Pharmaceutical Factory (China)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Rosuvastatin Calcium Sale, by Type, Application, Distribution Channel, Form and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Rosuvastatin Calcium (Value)
      • 7.2.1. Global Rosuvastatin Calcium by: Type (Value)
        • 7.2.1.1. Purity 98.0%
        • 7.2.1.2. Purity 99.0%
        • 7.2.1.3. Other
      • 7.2.2. Global Rosuvastatin Calcium by: Application (Value)
        • 7.2.2.1. Capsule
        • 7.2.2.2. Gel
        • 7.2.2.3. Tablet
      • 7.2.3. Global Rosuvastatin Calcium by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
      • 7.2.4. Global Rosuvastatin Calcium by: Form (Value)
        • 7.2.4.1. Tablet
        • 7.2.4.2. Capsule
        • 7.2.4.3. Others
      • 7.2.5. Global Rosuvastatin Calcium Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Rosuvastatin Calcium (Volume)
      • 7.3.1. Global Rosuvastatin Calcium by: Type (Volume)
        • 7.3.1.1. Purity 98.0%
        • 7.3.1.2. Purity 99.0%
        • 7.3.1.3. Other
      • 7.3.2. Global Rosuvastatin Calcium by: Application (Volume)
        • 7.3.2.1. Capsule
        • 7.3.2.2. Gel
        • 7.3.2.3. Tablet
      • 7.3.3. Global Rosuvastatin Calcium by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital Pharmacies
        • 7.3.3.2. Retail Pharmacies
        • 7.3.3.3. Online Pharmacies
      • 7.3.4. Global Rosuvastatin Calcium by: Form (Volume)
        • 7.3.4.1. Tablet
        • 7.3.4.2. Capsule
        • 7.3.4.3. Others
      • 7.3.5. Global Rosuvastatin Calcium Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Rosuvastatin Calcium (Price)
      • 7.4.1. Global Rosuvastatin Calcium by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rosuvastatin Calcium: by Type(USD Million)
  • Table 2. Rosuvastatin Calcium Purity 98.0% , by Region USD Million (2016-2021)
  • Table 3. Rosuvastatin Calcium Purity 99.0% , by Region USD Million (2016-2021)
  • Table 4. Rosuvastatin Calcium Other , by Region USD Million (2016-2021)
  • Table 5. Rosuvastatin Calcium: by Application(USD Million)
  • Table 6. Rosuvastatin Calcium Capsule , by Region USD Million (2016-2021)
  • Table 7. Rosuvastatin Calcium Gel , by Region USD Million (2016-2021)
  • Table 8. Rosuvastatin Calcium Tablet , by Region USD Million (2016-2021)
  • Table 9. Rosuvastatin Calcium: by Distribution Channel(USD Million)
  • Table 10. Rosuvastatin Calcium Hospital Pharmacies , by Region USD Million (2016-2021)
  • Table 11. Rosuvastatin Calcium Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 12. Rosuvastatin Calcium Online Pharmacies , by Region USD Million (2016-2021)
  • Table 13. Rosuvastatin Calcium: by Form(USD Million)
  • Table 14. Rosuvastatin Calcium Tablet , by Region USD Million (2016-2021)
  • Table 15. Rosuvastatin Calcium Capsule , by Region USD Million (2016-2021)
  • Table 16. Rosuvastatin Calcium Others , by Region USD Million (2016-2021)
  • Table 17. South America Rosuvastatin Calcium, by Country USD Million (2016-2021)
  • Table 18. South America Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 19. South America Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 20. South America Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 21. South America Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 22. Brazil Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 23. Brazil Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 24. Brazil Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 25. Brazil Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 26. Argentina Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 27. Argentina Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 28. Argentina Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 29. Argentina Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 30. Rest of South America Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 31. Rest of South America Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 32. Rest of South America Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 33. Rest of South America Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 34. Asia Pacific Rosuvastatin Calcium, by Country USD Million (2016-2021)
  • Table 35. Asia Pacific Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 36. Asia Pacific Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 37. Asia Pacific Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 38. Asia Pacific Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 39. China Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 40. China Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 41. China Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 42. China Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 43. Japan Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 44. Japan Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 45. Japan Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 46. Japan Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 47. India Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 48. India Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 49. India Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 50. India Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 51. South Korea Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 52. South Korea Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 53. South Korea Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 54. South Korea Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 55. Taiwan Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 56. Taiwan Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 57. Taiwan Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 58. Taiwan Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 59. Australia Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 60. Australia Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 61. Australia Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 62. Australia Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 67. Europe Rosuvastatin Calcium, by Country USD Million (2016-2021)
  • Table 68. Europe Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 69. Europe Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 70. Europe Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 71. Europe Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 72. Germany Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 73. Germany Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 74. Germany Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 75. Germany Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 76. France Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 77. France Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 78. France Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 79. France Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 80. Italy Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 81. Italy Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 82. Italy Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 83. Italy Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 84. United Kingdom Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 85. United Kingdom Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 86. United Kingdom Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 87. United Kingdom Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 88. Netherlands Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 89. Netherlands Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 90. Netherlands Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 91. Netherlands Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 92. Rest of Europe Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 93. Rest of Europe Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 94. Rest of Europe Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 95. Rest of Europe Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 96. MEA Rosuvastatin Calcium, by Country USD Million (2016-2021)
  • Table 97. MEA Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 98. MEA Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 99. MEA Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 100. MEA Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 101. Middle East Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 102. Middle East Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 103. Middle East Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 104. Middle East Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 105. Africa Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 106. Africa Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 107. Africa Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 108. Africa Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 109. North America Rosuvastatin Calcium, by Country USD Million (2016-2021)
  • Table 110. North America Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 111. North America Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 112. North America Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 113. North America Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 114. United States Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 115. United States Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 116. United States Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 117. United States Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 118. Canada Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 119. Canada Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 120. Canada Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 121. Canada Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 122. Mexico Rosuvastatin Calcium, by Type USD Million (2016-2021)
  • Table 123. Mexico Rosuvastatin Calcium, by Application USD Million (2016-2021)
  • Table 124. Mexico Rosuvastatin Calcium, by Distribution Channel USD Million (2016-2021)
  • Table 125. Mexico Rosuvastatin Calcium, by Form USD Million (2016-2021)
  • Table 126. Rosuvastatin Calcium Sales: by Type(K Unit)
  • Table 127. Rosuvastatin Calcium Sales Purity 98.0% , by Region K Unit (2016-2021)
  • Table 128. Rosuvastatin Calcium Sales Purity 99.0% , by Region K Unit (2016-2021)
  • Table 129. Rosuvastatin Calcium Sales Other , by Region K Unit (2016-2021)
  • Table 130. Rosuvastatin Calcium Sales: by Application(K Unit)
  • Table 131. Rosuvastatin Calcium Sales Capsule , by Region K Unit (2016-2021)
  • Table 132. Rosuvastatin Calcium Sales Gel , by Region K Unit (2016-2021)
  • Table 133. Rosuvastatin Calcium Sales Tablet , by Region K Unit (2016-2021)
  • Table 134. Rosuvastatin Calcium Sales: by Distribution Channel(K Unit)
  • Table 135. Rosuvastatin Calcium Sales Hospital Pharmacies , by Region K Unit (2016-2021)
  • Table 136. Rosuvastatin Calcium Sales Retail Pharmacies , by Region K Unit (2016-2021)
  • Table 137. Rosuvastatin Calcium Sales Online Pharmacies , by Region K Unit (2016-2021)
  • Table 138. Rosuvastatin Calcium Sales: by Form(K Unit)
  • Table 139. Rosuvastatin Calcium Sales Tablet , by Region K Unit (2016-2021)
  • Table 140. Rosuvastatin Calcium Sales Capsule , by Region K Unit (2016-2021)
  • Table 141. Rosuvastatin Calcium Sales Others , by Region K Unit (2016-2021)
  • Table 142. South America Rosuvastatin Calcium Sales, by Country K Unit (2016-2021)
  • Table 143. South America Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 144. South America Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 145. South America Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 146. South America Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 147. Brazil Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 148. Brazil Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 149. Brazil Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 150. Brazil Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 151. Argentina Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 152. Argentina Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 153. Argentina Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 154. Argentina Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 155. Rest of South America Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 156. Rest of South America Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 157. Rest of South America Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 158. Rest of South America Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 159. Asia Pacific Rosuvastatin Calcium Sales, by Country K Unit (2016-2021)
  • Table 160. Asia Pacific Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 161. Asia Pacific Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 162. Asia Pacific Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 163. Asia Pacific Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 164. China Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 165. China Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 166. China Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 167. China Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 168. Japan Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 169. Japan Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 170. Japan Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 171. Japan Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 172. India Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 173. India Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 174. India Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 175. India Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 176. South Korea Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 177. South Korea Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 178. South Korea Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 179. South Korea Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 180. Taiwan Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 181. Taiwan Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 182. Taiwan Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 183. Taiwan Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 184. Australia Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 185. Australia Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 186. Australia Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 187. Australia Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 188. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 189. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 190. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 191. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 192. Europe Rosuvastatin Calcium Sales, by Country K Unit (2016-2021)
  • Table 193. Europe Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 194. Europe Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 195. Europe Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 196. Europe Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 197. Germany Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 198. Germany Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 199. Germany Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 200. Germany Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 201. France Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 202. France Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 203. France Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 204. France Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 205. Italy Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 206. Italy Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 207. Italy Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 208. Italy Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 209. United Kingdom Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 210. United Kingdom Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 211. United Kingdom Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 212. United Kingdom Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 213. Netherlands Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 214. Netherlands Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 215. Netherlands Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 216. Netherlands Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 217. Rest of Europe Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 218. Rest of Europe Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 219. Rest of Europe Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 220. Rest of Europe Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 221. MEA Rosuvastatin Calcium Sales, by Country K Unit (2016-2021)
  • Table 222. MEA Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 223. MEA Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 224. MEA Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 225. MEA Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 226. Middle East Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 227. Middle East Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 228. Middle East Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 229. Middle East Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 230. Africa Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 231. Africa Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 232. Africa Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 233. Africa Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 234. North America Rosuvastatin Calcium Sales, by Country K Unit (2016-2021)
  • Table 235. North America Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 236. North America Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 237. North America Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 238. North America Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 239. United States Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 240. United States Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 241. United States Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 242. United States Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 243. Canada Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 244. Canada Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 245. Canada Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 246. Canada Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 247. Mexico Rosuvastatin Calcium Sales, by Type K Unit (2016-2021)
  • Table 248. Mexico Rosuvastatin Calcium Sales, by Application K Unit (2016-2021)
  • Table 249. Mexico Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2016-2021)
  • Table 250. Mexico Rosuvastatin Calcium Sales, by Form K Unit (2016-2021)
  • Table 251. Rosuvastatin Calcium: by Type(USD/Units)
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Rosuvastatin Calcium: by Type(USD Million)
  • Table 264. Rosuvastatin Calcium Purity 98.0% , by Region USD Million (2022-2027)
  • Table 265. Rosuvastatin Calcium Purity 99.0% , by Region USD Million (2022-2027)
  • Table 266. Rosuvastatin Calcium Other , by Region USD Million (2022-2027)
  • Table 267. Rosuvastatin Calcium: by Application(USD Million)
  • Table 268. Rosuvastatin Calcium Capsule , by Region USD Million (2022-2027)
  • Table 269. Rosuvastatin Calcium Gel , by Region USD Million (2022-2027)
  • Table 270. Rosuvastatin Calcium Tablet , by Region USD Million (2022-2027)
  • Table 271. Rosuvastatin Calcium: by Distribution Channel(USD Million)
  • Table 272. Rosuvastatin Calcium Hospital Pharmacies , by Region USD Million (2022-2027)
  • Table 273. Rosuvastatin Calcium Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 274. Rosuvastatin Calcium Online Pharmacies , by Region USD Million (2022-2027)
  • Table 275. Rosuvastatin Calcium: by Form(USD Million)
  • Table 276. Rosuvastatin Calcium Tablet , by Region USD Million (2022-2027)
  • Table 277. Rosuvastatin Calcium Capsule , by Region USD Million (2022-2027)
  • Table 278. Rosuvastatin Calcium Others , by Region USD Million (2022-2027)
  • Table 279. South America Rosuvastatin Calcium, by Country USD Million (2022-2027)
  • Table 280. South America Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 281. South America Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 282. South America Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 283. South America Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 284. Brazil Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 285. Brazil Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 286. Brazil Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 287. Brazil Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 288. Argentina Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 289. Argentina Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 290. Argentina Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 291. Argentina Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 292. Rest of South America Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 293. Rest of South America Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 294. Rest of South America Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 295. Rest of South America Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 296. Asia Pacific Rosuvastatin Calcium, by Country USD Million (2022-2027)
  • Table 297. Asia Pacific Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 298. Asia Pacific Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 299. Asia Pacific Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 300. Asia Pacific Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 301. China Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 302. China Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 303. China Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 304. China Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 305. Japan Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 306. Japan Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 307. Japan Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 308. Japan Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 309. India Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 310. India Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 311. India Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 312. India Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 313. South Korea Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 314. South Korea Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 315. South Korea Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 316. South Korea Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 317. Taiwan Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 318. Taiwan Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 319. Taiwan Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 320. Taiwan Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 321. Australia Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 322. Australia Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 323. Australia Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 324. Australia Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 325. Rest of Asia-Pacific Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 326. Rest of Asia-Pacific Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 327. Rest of Asia-Pacific Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 328. Rest of Asia-Pacific Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 329. Europe Rosuvastatin Calcium, by Country USD Million (2022-2027)
  • Table 330. Europe Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 331. Europe Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 332. Europe Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 333. Europe Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 334. Germany Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 335. Germany Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 336. Germany Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 337. Germany Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 338. France Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 339. France Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 340. France Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 341. France Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 342. Italy Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 343. Italy Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 344. Italy Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 345. Italy Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 346. United Kingdom Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 347. United Kingdom Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 348. United Kingdom Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 349. United Kingdom Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 350. Netherlands Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 351. Netherlands Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 352. Netherlands Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 353. Netherlands Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 354. Rest of Europe Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 355. Rest of Europe Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 356. Rest of Europe Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 357. Rest of Europe Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 358. MEA Rosuvastatin Calcium, by Country USD Million (2022-2027)
  • Table 359. MEA Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 360. MEA Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 361. MEA Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 362. MEA Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 363. Middle East Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 364. Middle East Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 365. Middle East Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 366. Middle East Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 367. Africa Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 368. Africa Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 369. Africa Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 370. Africa Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 371. North America Rosuvastatin Calcium, by Country USD Million (2022-2027)
  • Table 372. North America Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 373. North America Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 374. North America Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 375. North America Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 376. United States Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 377. United States Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 378. United States Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 379. United States Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 380. Canada Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 381. Canada Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 382. Canada Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 383. Canada Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 384. Mexico Rosuvastatin Calcium, by Type USD Million (2022-2027)
  • Table 385. Mexico Rosuvastatin Calcium, by Application USD Million (2022-2027)
  • Table 386. Mexico Rosuvastatin Calcium, by Distribution Channel USD Million (2022-2027)
  • Table 387. Mexico Rosuvastatin Calcium, by Form USD Million (2022-2027)
  • Table 388. Rosuvastatin Calcium Sales: by Type(K Unit)
  • Table 389. Rosuvastatin Calcium Sales Purity 98.0% , by Region K Unit (2022-2027)
  • Table 390. Rosuvastatin Calcium Sales Purity 99.0% , by Region K Unit (2022-2027)
  • Table 391. Rosuvastatin Calcium Sales Other , by Region K Unit (2022-2027)
  • Table 392. Rosuvastatin Calcium Sales: by Application(K Unit)
  • Table 393. Rosuvastatin Calcium Sales Capsule , by Region K Unit (2022-2027)
  • Table 394. Rosuvastatin Calcium Sales Gel , by Region K Unit (2022-2027)
  • Table 395. Rosuvastatin Calcium Sales Tablet , by Region K Unit (2022-2027)
  • Table 396. Rosuvastatin Calcium Sales: by Distribution Channel(K Unit)
  • Table 397. Rosuvastatin Calcium Sales Hospital Pharmacies , by Region K Unit (2022-2027)
  • Table 398. Rosuvastatin Calcium Sales Retail Pharmacies , by Region K Unit (2022-2027)
  • Table 399. Rosuvastatin Calcium Sales Online Pharmacies , by Region K Unit (2022-2027)
  • Table 400. Rosuvastatin Calcium Sales: by Form(K Unit)
  • Table 401. Rosuvastatin Calcium Sales Tablet , by Region K Unit (2022-2027)
  • Table 402. Rosuvastatin Calcium Sales Capsule , by Region K Unit (2022-2027)
  • Table 403. Rosuvastatin Calcium Sales Others , by Region K Unit (2022-2027)
  • Table 404. South America Rosuvastatin Calcium Sales, by Country K Unit (2022-2027)
  • Table 405. South America Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 406. South America Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 407. South America Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 408. South America Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 409. Brazil Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 410. Brazil Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 411. Brazil Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 412. Brazil Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 413. Argentina Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 414. Argentina Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 415. Argentina Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 416. Argentina Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 417. Rest of South America Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 418. Rest of South America Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 419. Rest of South America Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 420. Rest of South America Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 421. Asia Pacific Rosuvastatin Calcium Sales, by Country K Unit (2022-2027)
  • Table 422. Asia Pacific Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 423. Asia Pacific Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 424. Asia Pacific Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 425. Asia Pacific Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 426. China Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 427. China Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 428. China Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 429. China Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 430. Japan Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 431. Japan Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 432. Japan Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 433. Japan Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 434. India Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 435. India Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 436. India Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 437. India Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 438. South Korea Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 439. South Korea Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 440. South Korea Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 441. South Korea Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 442. Taiwan Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 443. Taiwan Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 444. Taiwan Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 445. Taiwan Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 446. Australia Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 447. Australia Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 448. Australia Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 449. Australia Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 450. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 451. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 452. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 453. Rest of Asia-Pacific Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 454. Europe Rosuvastatin Calcium Sales, by Country K Unit (2022-2027)
  • Table 455. Europe Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 456. Europe Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 457. Europe Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 458. Europe Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 459. Germany Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 460. Germany Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 461. Germany Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 462. Germany Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 463. France Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 464. France Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 465. France Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 466. France Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 467. Italy Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 468. Italy Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 469. Italy Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 470. Italy Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 471. United Kingdom Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 472. United Kingdom Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 473. United Kingdom Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 474. United Kingdom Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 475. Netherlands Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 476. Netherlands Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 477. Netherlands Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 478. Netherlands Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 479. Rest of Europe Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 480. Rest of Europe Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 481. Rest of Europe Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 482. Rest of Europe Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 483. MEA Rosuvastatin Calcium Sales, by Country K Unit (2022-2027)
  • Table 484. MEA Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 485. MEA Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 486. MEA Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 487. MEA Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 488. Middle East Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 489. Middle East Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 490. Middle East Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 491. Middle East Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 492. Africa Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 493. Africa Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 494. Africa Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 495. Africa Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 496. North America Rosuvastatin Calcium Sales, by Country K Unit (2022-2027)
  • Table 497. North America Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 498. North America Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 499. North America Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 500. North America Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 501. United States Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 502. United States Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 503. United States Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 504. United States Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 505. Canada Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 506. Canada Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 507. Canada Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 508. Canada Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 509. Mexico Rosuvastatin Calcium Sales, by Type K Unit (2022-2027)
  • Table 510. Mexico Rosuvastatin Calcium Sales, by Application K Unit (2022-2027)
  • Table 511. Mexico Rosuvastatin Calcium Sales, by Distribution Channel K Unit (2022-2027)
  • Table 512. Mexico Rosuvastatin Calcium Sales, by Form K Unit (2022-2027)
  • Table 513. Rosuvastatin Calcium: by Type(USD/Units)
  • Table 514. Research Programs/Design for This Report
  • Table 515. Key Data Information from Secondary Sources
  • Table 516. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rosuvastatin Calcium: by Type USD Million (2016-2021)
  • Figure 5. Global Rosuvastatin Calcium: by Application USD Million (2016-2021)
  • Figure 6. Global Rosuvastatin Calcium: by Distribution Channel USD Million (2016-2021)
  • Figure 7. Global Rosuvastatin Calcium: by Form USD Million (2016-2021)
  • Figure 8. South America Rosuvastatin Calcium Share (%), by Country
  • Figure 9. Asia Pacific Rosuvastatin Calcium Share (%), by Country
  • Figure 10. Europe Rosuvastatin Calcium Share (%), by Country
  • Figure 11. MEA Rosuvastatin Calcium Share (%), by Country
  • Figure 12. North America Rosuvastatin Calcium Share (%), by Country
  • Figure 13. Global Rosuvastatin Calcium: by Type K Unit (2016-2021)
  • Figure 14. Global Rosuvastatin Calcium: by Application K Unit (2016-2021)
  • Figure 15. Global Rosuvastatin Calcium: by Distribution Channel K Unit (2016-2021)
  • Figure 16. Global Rosuvastatin Calcium: by Form K Unit (2016-2021)
  • Figure 17. South America Rosuvastatin Calcium Share (%), by Country
  • Figure 18. Asia Pacific Rosuvastatin Calcium Share (%), by Country
  • Figure 19. Europe Rosuvastatin Calcium Share (%), by Country
  • Figure 20. MEA Rosuvastatin Calcium Share (%), by Country
  • Figure 21. North America Rosuvastatin Calcium Share (%), by Country
  • Figure 22. Global Rosuvastatin Calcium: by Type USD/Units (2016-2021)
  • Figure 23. Global Rosuvastatin Calcium share by Players 2021 (%)
  • Figure 24. Global Rosuvastatin Calcium share by Players (Top 3) 2021(%)
  • Figure 25. Global Rosuvastatin Calcium share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Nanjing Frochem Tech (China) Revenue, Net Income and Gross profit
  • Figure 28. Nanjing Frochem Tech (China) Revenue: by Geography 2021
  • Figure 29. Zhejiang Jingxin Pharmaceutical Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 30. Zhejiang Jingxin Pharmaceutical Co. Ltd. (China) Revenue: by Geography 2021
  • Figure 31. Cadila Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 32. Cadila Pharmaceuticals (India) Revenue: by Geography 2021
  • Figure 33. MSN Laboratories Pvt.Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 34. MSN Laboratories Pvt.Ltd. (India) Revenue: by Geography 2021
  • Figure 35. Lianyungang Runzhong Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 36. Lianyungang Runzhong Pharmaceutical (China) Revenue: by Geography 2021
  • Figure 37. LGM Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 38. LGM Pharma (United States) Revenue: by Geography 2021
  • Figure 39. CTX Life Sciences Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 40. CTX Life Sciences Pvt. Ltd. (India) Revenue: by Geography 2021
  • Figure 41. HEC Pharma Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 42. HEC Pharma Co., Ltd (China) Revenue: by Geography 2021
  • Figure 43. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 44. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2021
  • Figure 45. Bal Pharma Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 46. Bal Pharma Ltd. (India) Revenue: by Geography 2021
  • Figure 47. Changzhou Pharmaceutical Factory (China) Revenue, Net Income and Gross profit
  • Figure 48. Changzhou Pharmaceutical Factory (China) Revenue: by Geography 2021
  • Figure 49. Global Rosuvastatin Calcium: by Type USD Million (2022-2027)
  • Figure 50. Global Rosuvastatin Calcium: by Application USD Million (2022-2027)
  • Figure 51. Global Rosuvastatin Calcium: by Distribution Channel USD Million (2022-2027)
  • Figure 52. Global Rosuvastatin Calcium: by Form USD Million (2022-2027)
  • Figure 53. South America Rosuvastatin Calcium Share (%), by Country
  • Figure 54. Asia Pacific Rosuvastatin Calcium Share (%), by Country
  • Figure 55. Europe Rosuvastatin Calcium Share (%), by Country
  • Figure 56. MEA Rosuvastatin Calcium Share (%), by Country
  • Figure 57. North America Rosuvastatin Calcium Share (%), by Country
  • Figure 58. Global Rosuvastatin Calcium: by Type K Unit (2022-2027)
  • Figure 59. Global Rosuvastatin Calcium: by Application K Unit (2022-2027)
  • Figure 60. Global Rosuvastatin Calcium: by Distribution Channel K Unit (2022-2027)
  • Figure 61. Global Rosuvastatin Calcium: by Form K Unit (2022-2027)
  • Figure 62. South America Rosuvastatin Calcium Share (%), by Country
  • Figure 63. Asia Pacific Rosuvastatin Calcium Share (%), by Country
  • Figure 64. Europe Rosuvastatin Calcium Share (%), by Country
  • Figure 65. MEA Rosuvastatin Calcium Share (%), by Country
  • Figure 66. North America Rosuvastatin Calcium Share (%), by Country
  • Figure 67. Global Rosuvastatin Calcium: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Nanjing Frochem Tech (China)
  • Zhejiang Jingxin Pharmaceutical Co. Ltd. (China)
  • Cadila Pharmaceuticals (India)
  • MSN Laboratories Pvt.Ltd. (India)
  • Lianyungang Runzhong Pharmaceutical (China)
  • LGM Pharma (United States)
  • CTX Life Sciences Pvt. Ltd. (India)
  • HEC Pharma Co., Ltd (China)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bal Pharma Ltd. (India)
  • Changzhou Pharmaceutical Factory (China)
Additional players considered in the study are as follows:
Lunan Pharmaceutical (China) , Zhejiang Hisun Pharmaceutical Co., Ltd. (China)
Select User Access Type

Key Highlights of Report


Aug 2022 170 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rosuvastatin Calcium Quantitative research analysis
Global Rosuvastatin Calcium Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Nanjing Frochem Tech (China), Zhejiang Jingxin Pharmaceutical Co. Ltd. (China), Cadila Pharmaceuticals (India), MSN Laboratories Pvt.Ltd. (India), Lianyungang Runzhong Pharmaceutical (China), LGM Pharma (United States), CTX Life Sciences Pvt. Ltd. (India), HEC Pharma Co., Ltd (China), Teva Pharmaceutical Industries Ltd. (Israel), Bal Pharma Ltd. (India) and Changzhou Pharmaceutical Factory (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increased Demand from Developing Regions" is seen as one of major influencing trends for Rosuvastatin Calcium Market during projected period 2021-2027.
The Rosuvastatin Calcium market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Rosuvastatin Calcium Report?

Have a Query? Click Here

Other Related Reports

Krill Oil Comprehensive Study by Type (Liquid, Tablet), Application (Dietary Supplements, Pet and Animal Food, Food and Beverages, Pharmaceuticals), Distribution Channel (Offline, Online), Packaging ...
$ 3500
Codeine Phosphate Comprehensive Study by Type (Extracted from Opium, Synthesized by Morphine), Application (Narcotic Analgesic, Antitussive, Others), End-users (Hospitals, Clinics, Others), Distribut...
$ 3450
Active Pharmaceutical Ingredient Comprehensive Study by Type (Innovative, Generic), Application (Chemical, Deodorant, Others) Players and Region - Global Market Outlook to 2027
$ 3500
Prenatal Vitamins Supplements Comprehensive Study by Type (Folic Acid, Iron, Calcium, Vitamin D, Others), Application (Early Pregnancy, Late Pregnancy), Sales Channel (Pharmacies, Ecommerce, Others),...
$ 3350
Insulin Delivery Devices Comprehensive Study by Type (Syringes, Pens(Reusable Pens Disposable Pens), Jet injectors, Oral insulin, Pumps), Application (Cancer, Diabetes, Chronic Pains, Others), Dist...
$ 3450
CBD Oil Comprehensive Study by Type (Marijuana-Derived CBD Oil Products, Hemp-Derived CBD Oil Products), Application (Medical, Recreational), Distribution Channel (Hospital Pharmacies, Retail Pharmac...
$ 3650